These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The control of drugs and therapeutic freedom. Dunlop D Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368 [No Abstract] [Full Text] [Related]
25. [Drug samples for physicians]. Schulz G Ther Ggw; 1969 Feb; 108(2):299-302. PubMed ID: 5792520 [No Abstract] [Full Text] [Related]
26. Panel discussion: international drug regulations and their practical application. I. Swedish experience of drug regulations and their applications. Liljestrand A Bull Parenter Drug Assoc; 1974; 28(4):153-60. PubMed ID: 4853527 [No Abstract] [Full Text] [Related]
27. [Medical questions with respect to the introduction of new drug specialties into the German Federal Republic]. Grillmaier JB Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):315-31. PubMed ID: 5365590 [No Abstract] [Full Text] [Related]
28. Clinical pharmacology of drug metabolism and drug interactions: clinical, interethnical and regulatory aspects. Llerena A Drug Metabol Drug Interact; 2013; 28(1):1-3. PubMed ID: 23449520 [No Abstract] [Full Text] [Related]
29. [Europe and the drugs]. Duprat P Rev Prat; 1975 Jun; 25(34):2704-6. PubMed ID: 1162277 [No Abstract] [Full Text] [Related]
30. [Drug therapy under the responsibility of veterinarians]. Hegner D Berl Munch Tierarztl Wochenschr; 1975 Aug; 88(16):305-9. PubMed ID: 1164389 [No Abstract] [Full Text] [Related]
31. [The influence of the drug legislation on drug information for the physician and patient]. Schwabe U Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167 [No Abstract] [Full Text] [Related]
32. Problems regarding the introduction of a psychopharmaceutical agent in international markets. Chanas PJ Psychosomatics; 1970; 11(5):530-1. PubMed ID: 5470686 [No Abstract] [Full Text] [Related]
33. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry]. Lorusso S; Camoni I; Chiacchierini E Nuovi Ann Ig Microbiol; 1985; 36(3):169-80. PubMed ID: 3842759 [No Abstract] [Full Text] [Related]
34. [Drug effectiveness in the framework of drug legislation and health insurance law]. Töns H Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171 [No Abstract] [Full Text] [Related]
35. [Drugs: from research to consumer]. Krankenpflege (Frankf); 1978 Nov; 32(11):366-8. PubMed ID: 213643 [No Abstract] [Full Text] [Related]
36. [Generic drug: standards, organizational and economic aspects of the use of galenicals within the National Health Service]. Marchetti M; Riccieri FM Farmaco Prat; 1982 Jul; 37(7):215-25. PubMed ID: 7128772 [No Abstract] [Full Text] [Related]
37. [Communication of the board of directors of the Pharmacological Society and the commission drawing up directions for testing of new drugs]. Pharmakotherapia; 1964; 2(1):195-207. PubMed ID: 5875713 [No Abstract] [Full Text] [Related]
38. [Drugs and communication: ordination and value concept]. Faraco EZ AMB Rev Assoc Med Bras; 1981 May; 27(5):165-8. PubMed ID: 6976600 [No Abstract] [Full Text] [Related]
39. [Results in the identity tests of pharmaceutic specialties]. Wenk R; Schmid J Pharm Prax; 1970; 8():183-4. PubMed ID: 5508935 [No Abstract] [Full Text] [Related]
40. Basis for the assurance of safety, quality and efficacy of medicines in Ireland. Scott AI Ir Med J; 1985 Dec; 78(12):361-4. PubMed ID: 4086258 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]